| Code | 2607E | ||||||||||
| MA number | 53/0046/19-S | ||||||||||
| Product Form: | sol inr 100x10 ml/10 mg (striek.inj.napl.PP) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| Therapeutic Class: | 53 - PARASYMPATHOLYTICA, GANGLIOPLEGICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Container: | pre-filled syringe | ||||||||||
| Route of admin.: | Intravesical use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10a well-established use application |
| MA issued: | 20.02.2019 |
| Pediatric indication: | Yes |
| Pediatric posology: | Yes |
| Pediatric warnings: | Yes |
| PIL: |
PIL_Vesoxx 1mg_ml_sol inr_12_2022.pdf
|
| SPC: |
SPC_VESOXX 1mg_ml_sol inr_01_2024.pdf
|
| Safety feature | Yes |
| Data update: | 19.01.2024 |
